Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.

Nicholas WintersMireille E SchnitzerJonathon R CampbellSusannah RipleyCarla WinstonRada SavicNafees AhmadGregory BissonKeertan DhedaAli EsmailMedea GegiaIgnacio MonederoMargareth Maria Pretti DalcolmoDenise RodriguesRupak SinglaJae-Joon YimDick Menzies

Published in: PloS one (2023)

We describe a method to assess associations between clinical factors and treatment duration in observational studies of MDR/RR-TB patients, that may help identify patients who can benefit from shorter treatment.

Keyphrases

multidrug resistant
mycobacterium tuberculosis
end stage renal disease
chronic kidney disease
emergency department
drug resistant
combination therapy
hepatitis c virus
hiv aids
pulmonary tuberculosis
hiv infected
klebsiella pneumoniae